NCT00789360View on ClinicalTrials.gov

Staccato Loxapine Pulmonary Safety in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Healthy
Interventions
DRUG

Inhaled Placebo

Inhaled Staccato Placebo, 2 inhalations, 8 hours apart

DRUG

Inhaled Loxapine

Inhaled Staccato Loxapine, 10 mg doses x 2, 8 hours apart

Trial Locations (1)

02747

Northeast Medical Research, North Dartmouth

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY